The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial

BACKGROUND: The overdose epidemic in the United States has continued to worsen despite substantial efforts to mitigate its harms. The opioid antagonist naloxone has been identified as a key means of reducing the prevalence of fatal overdoses. An important evidence-based approach to optimizing naloxo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldridge, Lori Ann, Agley, Jon, Meyerson, Beth E, Golzarri-Arroyo, Lilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641511/
https://www.ncbi.nlm.nih.gov/pubmed/36279161
http://dx.doi.org/10.2196/42373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641511/
https://www.ncbi.nlm.nih.gov/pubmed/36279161
http://dx.doi.org/10.2196/42373

Ejemplares similares